Sedation in gastrointestinal endoscopy: Current issues
Open Access
- 1 January 2013
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 19 (4), 463-81
- https://doi.org/10.3748/wjg.v19.i4.463
Abstract
Diagnostic and therapeutic endoscopy can successfully be performed by applying moderate (conscious) sedation. Moderate sedation, using midazolam and an opioid, is the standard method of sedation, although propofol is increasingly being used in many countries because the satisfaction of endoscopists with propofol sedation is greater compared with their satisfaction with conventional sedation. Moreover, the use of propofol is currently preferred for the endoscopic sedation of patients with advanced liver disease due to its short biologic half-life and, consequently, its low risk of inducing hepatic encephalopathy. In the future, propofol could become the preferred sedation agent, especially for routine colonoscopy. Midazolam is the benzodiazepine of choice because of its shorter duration of action and better pharmacokinetic profile compared with diazepam. Among opioids, pethidine and fentanyl are the most popular. A number of other substances have been tested in several clinical trials with promising results. Among them, newer opioids, such as remifentanil, enable a faster recovery. The controversy regarding the administration of sedation by an endoscopist or an experienced nurse, as well as the optimal staffing of endoscopy units, continues to be a matter of discussion. Safe sedation in special clinical circumstances, such as in the cases of obese, pregnant, and elderly individuals, as well as patients with chronic lung, renal or liver disease, requires modification of the dose of the drugs used for sedation. In the great majority of patients, sedation under the supervision of a properly trained endoscopist remains the standard practice worldwide. In this review, an overview of the current knowledge concerning sedation during digestive endoscopy will be provided based on the data in the current literatureKeywords
This publication has 100 references indexed in Scilit:
- Patient-controlled Analgesia and Sedation With Alfentanyl Versus Fentanyl for ColonoscopyJournal of Clinical Gastroenterology, 2011
- Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized studyGastrointestinal Endoscopy, 2011
- Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled studyGastrointestinal Endoscopy, 2011
- Sedation during upper GI endoscopy in cirrhotic outpatients: a randomized, controlled trial comparing propofol and fentanyl with midazolam and fentanylGastrointestinal Endoscopy, 2011
- Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injectionThe Esophagus, 2010
- FospropofolDrugs, 2010
- Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patientsBMC Gastroenterology, 2010
- Midazolam with meperidine or fentanyl for colonoscopy: results of a randomized trialGastrointestinal Endoscopy, 2009
- Endoscopic Sedation in Developing and Developed CountriesGut and Liver, 2008
- Effect of music on procedure time and sedation during colonoscopy: A meta-analysisWorld Journal of Gastroenterology, 2008